EDTUTC-4 New YorkLog in Sign up

DSNKY
DAIICHI SANKYO S/ADR
stockOTCADR

EODOct 2, 2026

17.38USD+0.404%(+0.07)90,188

DSNKY News

Day breaks

02:55 AM EDTAstraZeneca, Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway-ivonescimab combo ·

Seeking Alpha

05:07 PM EDTMerck pulls BLA for antibody-drug conjugate I-DXd for small cell lung cancer ·

Seeking Alpha

09:50 AM EDTMerck, Astra, Roche and Corcept among winners of EU drug recommendations this week ·

Seeking Alpha

09:23 AM EDTAstra-Daiichi breast cancer drug Enhertu recommended for NHS use in England ·

Seeking Alpha

08:30 PM EDTMonoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 – SNS Insider ·

GlobeNewswire Inc.

10:10 AM EDTAZN Stock Down 20% in 6 Months: How to Play After Pipeline Setbacks ·

Zacks Investment Research

09:00 AM EDTBreast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider ·

GlobeNewswire Inc.